With a background as medical physicist, my research interest lies between imaging, nanomedicine, and oncology. I am a board certified Medical Physicist (France, DQPRM) with a PhD in nanomedicine. 

I actively worked on the development of the nanoparticle AGuIX, a silica-based gadolinium nanoparticle designed to act as a MR-guided radiation therapy agent with theranostic properties. AGuIX is currently being enrolled in a Phase I clinical trial in France.

Currently, I am working as a postdoctoral research fellow with joint position between the laboratory of Dr. Ghobrial at the Dana-Farber Cancer Institute/Harvard Medical School and the laboratory of Dr. Ghoroghchian at the Massachusetts Institute of Technology. My goal is to develop imaging biomarkers for the early detection of Multiple Myeloma. This include development of nanomedicine-based solution, including organic and inorganic nanoparticles as well as working on natural biomarkers allowing the direct prognostic of Multiple Myeloma.